Dr. Natarajan Elangovan, MD, MPH

Dr. Elangovan practices at Staten Island University Hospital - North Campus in Staten Island, New York.

Dr. Elangovan's NPI, 1649203530, was assigned on July 7, 2006. Dr. Elangovan holds New Jersey license 25MA06059400.

Dr. Elangovan's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 948-3864.

Dr. Elangovan's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dr. Elangovan is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Elangovan to 4 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elangovan practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Elangovan's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Elangovan is licensed in New Jersey.

CMS data shows 4,150 Medicare services from Dr. Elangovan across 3 procedure codes in 2024, for 272 Medicare patients. Medicare paid $307,612 for them. Every service was in an office.

CMS counts 272 Medicare patients who saw Dr. Elangovan in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have anxiety, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Elangovan's median patient age at 56, with 56% women.

In 2024, Dr. Elangovan wrote 2,541 Medicare Part D claims for 269 patients. 96% of them were for generic drugs. CMS names the drug for 2,425 of them, across 44 drugs with 11 or more claims each, at $61,841 in total drug cost. In 2023, CMS named 2,549 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 19 out of 100 for Dr. Elangovan for performance year 2024, reported individually. Dr. Elangovan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elangovan as offering telehealth.

Dmand AI links 3 papers to Dr. Elangovan, published from 2014 to 2018. Dr. Elangovan has published most often in Cureus. Dr. Elangovan's most frequent co-authors are Danielle Geraldi-Samara, MD and Ronald Wei, MD.

CMS Open Payments shows 14 general payments to Dr. Elangovan from 2 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $127.